17-10-9　ⓔ文献

  1. Chihara D, Ito H, et al: Differences in incidence and trends of haematological malignancies in Japan and the United States. Br J Haematol, 2014; 164: 536–545.

  2. 青木定夫：慢性リンパ性白血病．臨床血液，2014; 55: 213–222.

  3. Hallek M, Cheson BD, et al: iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL. Blood, 2018; 131: 2745–2560.

  4. Agathangelidis A, Vardi A, et al: Stereotyped B–cell receptors in chronic lymphocytic leukemia. Leuk Lymphoma, 2014; 55: 2252–2261.

  5. Swerdlow SH, Campo E, et al: Mantle cell lymphoma. WHO classification of tumours of haematopoietic and lymphoid tissues revised 4th ed (Swerdlow SH, Campo E, et al eds), IARC, 2017; 285–290.

  6. Piris MA, Pittaluga S, et al: Splenic marginal zone lymphoma. WHO classification of tumours of haematopoietic and lymphoid tissues revised 4th ed (Swerdlow SH, Campo E, et al eds), IARC, 2017; 223–225.

  7. Hallek M: Chronic lymphocytic leukemia: 2017 update on diagnosis, risk stratification, and treatment. Am J Hematol, 2017; 92: 946–965.

  8. 青木定夫：慢性リンパ性白血病．臨床血液，2016; 57: 238–548.

  9. Parikh SA: Chronic lymphocytic leukemia treatment algorithm 2018. Blood Cancer J, 2018; 8: 93.

  10. Gribben JG: How and when I do allogeneic transplant in CL. Blood, 2018; 132: 31–39.